A beta blockader for every postinfarct patient?
Meister, W.
Münchener Medizinische Wochenschrift 125(46): 1055-1056
1983
ISSN/ISBN: 0341-3098 PMID: 6139752 Document Number: 210899
Document emailed within 1 workday
Related Documents
Zdichynec, B. 1977: Treatment of supraventricular arrhythmias using the beta-blockader Visken Zeitschrift für Arztliche Fortbildung 71(10): 478Rudloff, P.R.; Bostedt, H. 1984: Effect of the beta blockader carazolol (Suacron) on parturition in sows Tierarztliche Praxis 12(4): 443-449
Vágfalvy, I.; Fehér, L. 1970: The use of iproveratril (a beta receptor blockader) in the treatment of thyrotixic crisis Orvosi Hetilap 111(12): 685-687
Mangiameli, S.; Circo, A.; Lombardo, D.; Branca, F.; Galassi, A. 1974: Beta blockader-quinidine combination in atrial fibrillation of thyroid patients Bollettino Della Societa Italiana di Cardiologia 19(6): 615-624
Silverii, A.; Bonolis, G.; Tomassini, P.K.; Campa, P.P. 1972: Effect of a beta-blockader on postural arterial reflectivity in normal subjects Bollettino Della Societa Italiana di Cardiologia 17(8): 503-508
Ustinova, E.E. 1983: Prevention of stress and hypoxic damage to the heart using the beta-blockader inderal Kardiologiia 23(7): 90-93
Savenkov, P.M.; Doshitsin, V.L.; Grudtsyn, G.V. 1977: Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension Kardiologiia 17(10): 62-66
Angelov, E.; Aleksieva, S. 1982: Inhibitory effect of beta blockader propranolol on demethylating activity of liver microsomes Eksperimentalna Meditsina i Morfologiia 21(1): 9-13
Bergmann, K.; Horák, O. 1970: Trimepranol, a new Czechoslovak sympatholytic beta receptor blockader. I. in angina pectoris therapy Casopis Lekaru Ceskych 109(22): 473-476
Gränzer, W.; Eichinger, H. 1982: Inhibition of isoprenaline-induced tachycardia in calves with the beta-receptor blockader carazolol Berliner und Munchener Tierarztliche Wochenschrift 95(3): 47-49
Cybulska, I.; Sznajderman, M.; Brym, E.; Czerniewska, E. 1981: Own experience with labetalol - a new adrenergic alpha and beta receptor blockader - in the treatment of arterial hypertension Polski Tygodnik Lekarski 36(34): 1309-1311
Hoppe, H.J.; Krüger, K.; Rosenthal, J.; Schrey, A.; Eberhardt, R. 1980: Beta blockader treatment in ambulatory hypertension care. a multicentric long-term study ZFA. Zeitschrift für Allgemeinmedizin 56(7): 496-504
Friedemann, M. 1975: Treatment of rhythm disorders following acute heart infarction using a beta receptor blockader (Visken) Schweizerische Medizinische Wochenschrift 105(30): 957-961
Flouvat, B.; Bazin, M.; Lucsko, M.; Roux, A.; Guedon, J. 1978: Spectrofluorimetric estimation in biological fluids of a new beta-blockader: atenolol. Application to its pharmacokinetic study Annales de Biologie Clinique 36(4): 339-346
Stephan, K.; Meesmann, W.; Amann, L.; Tacke, E.; Tüttemann, J. 1972: Effects of a heart specific beta blockader (practolol) following acute experimental coronary occlusion Verhandlungen der Deutschen Gesellschaft für Innere Medizin 78: 1029-1033
Hammerl, H.; Kränzl, C.; Nebosis, G.; Pichler, O.; Studlar, M. 1972: Metabolic studies and therapeutic experiences with the beta-receptor blockader 4-(2-hydroxy-3-isopropylamino-propoxy)-indol (LB 46) Arzneimittel-Forschung 22(6): 1055-1061
Actis, E.; Amato, E.A.; Palmero, H.A.; Rebora, E.H.; Fernández Vidal, J.M. 1978: Antihypertensive effect of the association of a beta adrenergic blockader, a vasodilator and a diuretic in slightly uremic hypertensive patients Medicina 38(6 Pt 1): 673-678
Takenaka, F.; Ishihara, T.; Maruyama, Y.; Matsumoto, S.; Inoue, H. 1974: Effects of an adrenergic beta-receptor blockader, 2-acetyl-7-(2-hydroxy-3-isopropylamino) propoxybenzofuran hydrochloride on the cardiovascular system Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 70(3): 385-397
De Petra, V.; Di Michele, R.; Cecchetti, E. 1973: Effects of an adrenergic beta receptor blockader on exercise tolerance and myocardial function in patients with angina pectoris Minerva Cardioangiologica 21(9): 619-624
Marchetti, G.; Merlo, L.; Noseda, V. 1973: Myocardial consumption of free fatty acids and carbohydrates following treatment with a new beta-blockader (1-o-methoxyphenoxy-3-isopropylamino-2-propanol HC1) D 1601 Bollettino Della Societa Italiana di Cardiologia 18(7): 672-675